University of North Carolina at Chapel Hill, Chapel Hill, NC
Dawn Odom, MS, is the Vice President of Biostatistics at RTI-HS. She has 25 years of professional experience working with real world and clinical trial data. During this time, she has worked as a statistician in numerous therapeutic areas, with a focus on oncology and gastroenterology. She has key regulatory experience, having participated in numerous FDA meetings. Her responsibilities at RTI-HS include statistical consulting, protocol development, creation of statistical analysis plans, production of analysis tables and listings, and report and publication development. She has extensive experience planning and conducting analysis of patient-reported outcomes particularly in oncology studies, with numerous publications in this area. Her experience spans both the analysis of randomized and observational studies, with in-depth experience analyzing data with informative missing data. She has also led numerous meta-analysis projects where she has applied statistical techniques such as meta-regression, mixed-treatment comparisons, and matching-adjusted indirect comparisons. In addition, Ms. Odom has worked as a survey statistician on a large national household survey where she was responsible for sample selection, item imputation, analysis tables, and report writing. She has extensive experience with the SAS programming language. Ms. Odom is a member of the American Statistical Association and the International Society of Pharmacoeconomics and Outcomes Research.